Approximately USD 10.8 Million Invested in New Drug Developm

Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions

Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions

prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Germany , Switzerland , Japan , Tokyo , Nagasaki , Yamagata , India , Bonn , Nordrhein Westfalen , Japanese , Mina Ohata , Nancy Moss , Product Development Platform , Wellcome , Mitsubishi Tanabe Pharma Corporation , Scripps Research Institute , Global Health Innovative Technology Fund , Melinda Gates Foundation , University Of Dundee , United Nations Development Programme , Clinical Development , Scripps Research Institute United States , Mitsubishi Tanabe Pharma Corporation Japan , National Institute Of Infectious Diseases Japan , Eisai Co Ltd , Mitsubishi Tanabe Pharma Co , Shionogi Co Ltd , Nagasaki University , Nagasaki University Japan , Helmholtz Centre For Infection Research , University Hospital Bonn , National Institute Of Infectious Diseases , Global Health Innovative Technology , International Centre For Genetic Engineering , National Institute , Infectious Diseases , Malaria Venture , International Centre , Genetic Engineering , Helmholtz Centre , Infection Research , Neglected Diseases , United States , Hospital Bonn , Tanabe Pharma Corporation , Target Candidate Profile , Drug Metabolism , Mitsubishi Tanabe Pharma , Health Innovative Technology Fund ,